Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy

Ying Gao,1 Lu Li,1 Fang Zhao,1 Yi Cheng,1 Mu Jin,2 Fu-Shan Xue1,3 1Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People’s Republi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Gao Y, Li L, Zhao F, Cheng Y, Jin M, Xue FS
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2025-01-01
Col·lecció:	Drug Design, Development and Therapy
Matèries:	cerebral ischemia/reperfusion injury esketamine microglia polarization autophagy ischemic stroke
Accés en línia:	https://www.dovepress.com/esketamine-at-a-clinical-dose-attenuates-cerebral-ischemiareperfusion--peer-reviewed-fulltext-article-DDDT
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!